Rare diseases framework flags role for data, tech and collaboration
Effectively harnessing advances in science, better use of data and digital technologies, and collaborative working across public health bodies and the life sciences industry, both nationally and internationally, are among the factors required to speed up the diagnosis and treatment of rare diseases, the governments of the four nations of the UK have agreed.
